NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...
As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...
Exclusive: Scientists uncovered biological strands using artificial intelligence and hope discovery will revolutionise treatment ...
By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...
NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...
Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated ...
Irish Examiner on MSN
Virtual reality helping patients in chronic pain
Virtual reality has become part of how chronic pain is treated, including for patients in public hospitals in Limerick and ...
The FDA has rejected Sanofi's application seeking approval of tolebrutinib to treat certain forms of MS in its present form.
The festive period brought some unwanted post for both Sanofi and Corcept Therapeutics in the form of FDA rejections for the ...
VIENNA, VA, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- The Chesapeake Foot & Ankle Institute, a trusted ...
A woman is raffling her Roughlee home to fund potentially life-saving cancer treatment in Germany. Claire Nutter, 48, was diagnosed with oligodendroglioma, a slow-growing brain tumour, in 2023. Her ...
"Beyond typical flu symptoms like fever, cough and body aches, warning signs include trouble breathing, chest pain, confusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results